April 2015 Newsletter
**IASLC Members in Nepal**
GAIN Programs - United States Locations
Take part in this important educational initiative, and you will have the opportunity to earn CME credit and gain access to performance improvement activities developed by CHEST, the American Society for Clinical Pathology, the National Comprehensive Cancer Network® (NCCN®), IASLC and The France Foundation.
May 2, 2015 | Seattle, WA | Contact: firstname.lastname@example.org | View Details
GAIN Programs - European Locations
GAIN is an interdisciplinary summit that seeks to address clinical gaps in the diagnosis and care of patients with locally advanced and metastatic non-small cell lung cancer (NSCLC). The goal is to improve performance of a team of specialists who are responsible for appropriate staging, mediastinal lymph node assessment, tissue acquisition, biomarker analysis and immunotherapy in patients with NSCLC. View details below or contact email@example.com.
IASLC Member Reception at ASCO Annual Meeting - Sunday, May 31, 2015
The Prevent Cancer Foundation and IASLC are proud to announce one 2-year Fellowship program. Applications are now requested. The award is $40,000 per year for 2 years and should have the focus on Prevention and Early Detection of Lung Cancer. The funding period will be August 1, 2015 – July 31, 2017. More
First Heine H. Hansen Award Given to Pieter E. Postmus
Member Access to Online Presentations from ELCC 2015
World Experts Gather for Refocusing on Patients with Small Cell Lung Cancer
IASLC Members Lead the Way on Stand Up to Cancer Lung Cancer Dream Team
IASLC Launches Online Nurses & Allied Health Professionals Resource Center
New Feature - May 2015: The International Association for the Study of Lung Cancer (IASLC) and the Journal of Thoracic Oncology (JTO) are pleased to present a new feature each month to highlight certain articles of interest. The selected articles each month will be made available to the public for a limited time at the time of print. The articles below from the May issue of JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada
Baumann and colleagues present interesting data with public health implications in terms of environmental asbestos exposure and the development of mesothelioma in young women in Nevada, USA. The manuscript - The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women from Southern Nevada Baumann et al - will undoubtedly generate debate in the public health community and is worthy of significant attention.
Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma
This article deals with the thorny issue of the response of uncommon EGFR mutations to EGFR tyrosine kinase inhibitors. In this comprehensive analysis from Hungary, the authors demonstrate that some rare EGFR mutations are associated with tobacco smoking, a poor response to EGFR TKIs and worse prognosis.
Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC
This is a timely topic with a paucity of data. The authors' elegant analysis provides useful information for clinicians and researchers in this area.
Hippo Pathway Gene Mutations in Malignant Mesothelioma: Revealed by RNA and Targeted Exon Sequencing
Miyanaga et al present their interesting data on molecular aberrations in the Hippo pathway in mesothelioma, elegantly revealed by their RNA and exome sequencing approaches.
The following articles have been selected by the IASLC Communications Committee from the JTO to be promoted to the media and the public with press releases that were released at the time of online publication (Published Ahead of Print). To read more IASLC Press Releases, please visit IASLC Research Articles. These press releases are also announced via social media, so please follow IASLC on Twitter and Facebook to stay up to date on the latest scientific topics!
The Women’s Health Initiative Studies, a large prospective study of lung cancer, found no strong associations between lung cancer risk and a wide range of reproductive history variables and only revealed weak support for a role of hormone use in the incidence of lung cancer.
Apr 8 2015 | More
Exercise and physical activity should be considered as therapeutic options for lung cancer as they have been shown to reduce symptoms, increase exercise tolerance, improve quality of life, and potentially reduce length of hospital stay and complications following surgery for lung cancer.
Apr 1 2015 | More
Low pre-surgery uptake of a labeled glucose analogue, a marker of metabolic activity, in the primary tumor of patients with stage I non-small cell lung cancer (NSCLC) is associated with increased overall survival and a longer time before tumor recurrence. Patients with high labeled glucose uptake may benefit from additional therapy following surgery.
Mar 26 2015 | More
The German Lung Cancer Screening Intervention Trial (LUSI) shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second and subsequent low-dose computed tomography (LDCT) screens, but emphasizes the need to have an organized screening program with the baseline scan available for comparison.
Mar 18 2015 | More
Membership in Russian Federation is US$50.00
2015 Member Directory is Online Now; Opt-in to Receive a Printed Version
IASLC Exhibit Booth and Joint Sessions
COMPLIMENTARY Fellows/Residents/Students/Trainees Membership – Group Program Registration
Renew IASLC Membership - All Categories – You will need to login with your email and password (you can use the “Forgot Password” option, if needed).
WCLC 2015: Free Attendance for Patients/Survivors!
Are you interested in getting more involved in IASLC?
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
WCLC Virtual Library
February 21 - 24 2018Santa Monica, California
March 22 - 24 2018Madrid, Spain
April 11 - 14 2018Geneva, Switzerland